Pharma Focus Asia

Pharma Press Releases

Keep up to date with the latest technological developments happening across the Pharmaceutical industry. Our press releases can help you boost your online reach and exposure worldwide. Our Press releases provides information on the latest research in pharma.

Bio-techne Announces New Distribution Agreement With Thermo Fisher Scientific

Tuesday, April 30, 2024

BioTechne Corporation a global life sciences company providing innovative tools and bioactive reagents for the research and clinical diagnostic communities is pleased to announce a significant milestone

Ractigen Therapeutics Announces FDA Approval for RAG-01, a First-in-Class saRNA Therapy for BCG-Unresponsive NMIBC

Monday, April 29, 2024

Ractigen Therapeutics a leader in the development of small activating RNA therapeutics announced today that the US Food and Drug Administration has approved the companys Investigational New Drug

HUTCHMED Announces Positive CHMP Opinion for Fruquintinib in Previously Treated Metastatic Colorectal Cancer Received by Takeda

Monday, April 29, 2024

HUTCHMED today announces that its partner Takeda received notification that the Committee for Medicinal Products for Human Use of the European Medicines Agency

ENA Respiratory Announces FDA IND Clearance for its Prophylactic Intranasal INNA-051 - a First-in-Class Antiviral Innate Immunomodulator

Monday, April 29, 2024

ENA Respiratory a clinicalstage pharmaceutical company developing innate immune modulators for the prevention of complications associated with respiratory viral infections in atrisk populations announces

Sino Biological Finalizes the Acquisition of SignalChem Biotech, Strengthening Global Presence and Expanding Product Portfolio

Monday, April 29, 2024

Sino Biological Inc a biotechnology company listed on the Shenzhen stock exchange subsidiary ChiNext specializing in biological research reagents and related technical contract research services

Prism Biolab, Enters Into a Joint Research and Licensing Agreement With Ono

Friday, April 26, 2024

PRISM BioLab Co Ltd a leading discovery and development biotechnology company designing small molecule inhibitors of proteinprotein interaction targets today announced that it has entered into a targetexclusive research and licensing agreement with O...

FDA grants Medivir´s MIV-711 Rare Pediatric Disease Designation and Orphan Drug Designation for the treatment of Legg-Calvé-Perthes Disease

Friday, April 26, 2024

Medivir AB a pharmaceutical company focused on developing innovative treatments for cancer in areas of high unmet medical need announced today that its selective cathepsin K inhibitor MIV has been granted

BioBased 96-well PCR Plates - Now also semi-skirted

Friday, April 26, 2024

Our customers depend on the high performance and reliability of the plates used in their highthroughput processes However increased throughput results in a higher carbon footprint

Cullinan Therapeutics to Present Phase 1 Clinical Data on CLN-619, a Novel Anti-MICA/B Antibody, at ASCO 2024

Thursday, April 25, 2024

Cullinan Therapeutics Inc a biopharmaceutical company focused on modalityagnostic targeted therapies today announced that clinical data from its Phase trial of CLN in patients with advanced solid tumors

Atom Bioscience Enrolling Patients in US as Part of a Global Phase 2b/3 Clinical Trial of a New Investigational Treatment for Chronic Gout

Thursday, April 25, 2024

Atom Bioscience a clinical stage biotechnology company developing new treatments for inflammatory and metabolic diseases has begun enrolling patients